
↳ NII Sub-Categories
sHNI (< ₹10L)
Bids ₹2L to ₹10L
bHNI (> ₹10L)
Bids above ₹10L
Overall Subscription
Total Bids Received
67.84x
Updated: 10 Jul, 06:09 pm
| Category | Shares Offered | % |
|---|---|---|
| NII | 28,89,926 | 14.83% |
| QIB | 38,53,234 | 19.78% |
| Anchor | 57,79,850 | 29.67% |
Emcure Pharmaceuticals Limited, an Indian pharmaceutical company, develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.The compan...
EPS (Pre-IPO)
29.17
EPS (Post-IPO)
27.95
P/E (Pre-IPO)
34.55
P/E (Post-IPO)
36.07
RoNW
16.87%
P/B Value
6.18
| Metric | FY 24 | FY 23 | FY 22 |
|---|---|---|---|
| Total Assets | 7806.16 | 6672.53 | 6063.47 |
| Total Revenue | 6715.24 | 6031.72 | 5918.86 |
| Profit After Tax | 527.58 | 561.85 | 702.56 |
| Net Worth | 2952.28 | 2501.13 | 1987.55 |
* All figures are in ₹ Crores unless otherwise stated.
Plot No. P-1 and P-2,, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune -411 057
Link Intime India Private Ltd
Get push notifications instantly when IPO allotment goes live!
Zero Brokerage Equity

India's #1 Stock Broker

Instant Demat Account
